JAMA. 2022 Oct 25;328(16):1624-1636. doi: 10.1001/jama.2022.18331.
PMID:36282253
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
Hu L, Napoletano A, Provenzano M, Garofalo C, Bini C, Comai G, La Manna G.
Int J Mol Sci. 2022 Oct 13;23(20):12223. doi: 10.3390/ijms232012223.
PMID:36293076
Cancer-related hypercalcemia and potential treatments.
Almuradova E, Cicin I.
Front Endocrinol (Lausanne). 2023 Mar 22;14:1039490. doi: 10.3389/fendo.2023.1039490. eCollection 2023.
PMID:37033238
Osteoporosis: Clinical Evaluation.
Lewiecki EM.
2024 Nov 2. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
PMID:25905277
Bisphosphonates and management of kidney stones and bone disease.
Prochaska M.
Curr Opin Nephrol Hypertens. 2021 Mar 1;30(2):184-189. doi: 10.1097/MNH.0000000000000682.
PMID:33394731
Hypophosphatasia.
Dahir KM, Nunes ME.
2007 Nov 20 [updated 2025 Mar 27]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
PMID:20301329
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z.
J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20.
PMID:35466448
Vascular calcification: Molecular mechanisms and therapeutic interventions.
Pan W, Jie W, Huang H.
MedComm (2020). 2023 Jan 3;4(1):e200. doi: 10.1002/mco2.200. eCollection 2023 Feb.
PMID:36620697
Treatment of Osteoporosis in Patients with Chronic Kidney Disease.
Laurent MR, Dupont J, Lemahieu W, Jamar S, Mellaerts B, Dejaeger M, Gielen E, Evenepoel P.
Curr Osteoporos Rep. 2025 Jun 2;23(1):26. doi: 10.1007/s11914-025-00919-0.